Botulinum toxin in tension-type headache;Botulinumtoxin beim kopfschmerz vom spannungstyp

Fortschritte der Neurologie Psychiatrie

Volumn 71, Issue 6, 2003, Pages 296-305

  Jost, W H ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CLOMIPRAMINE; CYPROHEPTADINE; DOXEPIN; ERGOTAMINE TARTRATE; IBUPROFEN; METHYLPREDNISOLONE; MONOAMINE OXIDASE INHIBITOR; MUSCLE RELAXANT AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIZOTIFEN; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ACUPUNCTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG APPROVAL; DRUG COST; DRUG EFFECT; DRUG INDICATION; HUMAN; INDIVIDUALITY; INJECTION SITE; MUSCLE DISEASE; MUSCLE ISCHEMIA; MUSCLE TONE; MYOFASCIAL PAIN; NERVE STIMULATION; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; STIMULUS RESPONSE; STRESS; TENSION HEADACHE; VASCULAR DISEASE;

BOTULINUM TOXINS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INJECTIONS, INTRAMUSCULAR; TENSION-TYPE HEADACHE;

EID: 0037789536     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39592     Document Type: Article

References (56)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7): 1-96
2. Rozen TD, Swanson JW, Stang PE, McDonnell SK, Rocca WA. Increasing incidence of medically recognized migraine headache in a United States population. Neurology 1999; 53: 1468-1473
3. Lipton RB, Goadsby P, Silberstein SD. Classification and epidemiology of headache. Clin Cornerstone 1999; 1: 1-10
4. Göbel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 1994; 14: 97-106
5. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998; 279: 381-383
6. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44: 1147-1157
7. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999; 53: 537-542
8. Oestergaard S, Russell MB, Bendtsen L, Olesen J. Increased familial risk of chronic tension-type headache. Br Med J 1997; 314: 1092-1093
9. Russel MB, Ostergaard S, Bendtsen L, Olesen J. Familial occurrence of chronic tension-type headache. Cephalalgia 1999; 19: 207-210
10. Bendtsen L, Jensen R, Hindberg I, Gammeltoft S, Olesen J. Serotonin metabolism in chronic tension-type headache. Cephalalgia 1997; 17: 843-848
11. Shimomura T, Awaki E, Kowa H, Takahashi K. Treatment of tension-type headache with tizanidine hydrochloride: its efficacy and relationship to the plasma MHPG concentration. Headache 1991; 31: 601-604
12. Castillo J, Martinez F, Leira R, Lema M, Noya M. Plasma monoamines in tension-type headache. Headache 1994; 34: 531-535
13. Mazzotta G, Sarchielli P, Gaggioli A, Gallai V. Study of pressure pain and cellular concentrations of neurotransmitters related to nociception in episodic tension-type headache patients. Headache 1997; 37: 565-571
14. Pfaffenrath V, Brune K, Diener HC, Gerber WD, Göbel H. Die Behandlung des Kopfschmerzes vom Spannungstyp. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 1998; 17: 91-100
15. Heckmann JG, Mück-Weymann M, Katalinic A, Hilz MJ, Claus D, Neundörfer B. TCD-Ergometer-Test bei Patienten mit chronischem Kopfschmerz vom Spannungstyp. Nervenarzt 1998; 69: 131-136
16. Hannerz J, Jogestrand T. Is chronic tension-type headache a vascular headache? The relation between chronic tension-type headache and cranial hemodynamics. Headache 1998; 38: 668-675
17. Jensen R. Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 1999; 19: 602-621
18. Göbel H. Die Kopfschmerzen. Heidelberg: Springer-Verlag, 1997
19. Clark GT, Sakai S, Merrill R, Flack VF, McCreary C. Cross-correlation between stress, pain, physical activity, and temporalis muscle EMG in tension-type headache. Cephalalgia 1995; 15: 511-518
20. Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain 1999; 79: 201-205
21. Jensen R, Rasmussen BK. Muscular disorders in tension-type headache. Cephalalgia 1996; 16: 97-103
22. Langemark M, Jensen K, Olesen J. Temporomuscle blood flow in chronic tension-type headache. Arch Neurol 1990; 47: 654-658
23. Jensen R, Bendtsen L, Olesen J. Muscular factors are of importance in tension-type headache. Headache 1998; 38: 10-17
24. Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998; 38: 468-471
25. Jensen R, Olesen J. Initiating mechanisms of experimentally induced tension-type headache. Cephalalgia 1996; 16: 175-182
26. Langemark M, Bach FW, Jensen TS, Olesen J. Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol 1993; 50: 1061-1064
27. Goadsby PJ. Chronic tension-type headache: where are we? Brain 1999; 122: 1611-1612
28. Sheftell FD. Chronic daily headache. Neurology 1992; 42 (suppl. 2): 32-36
29. Wöber-Bingöl C, Wöber C, Zeiler K, Heimberger K, Baumgartner C, Samec P, Wessely P. Tension headache and the cervical spine - plain X-ray findings. Cephalalgia 1992; 12: 152-154
30. Göbel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lindner V, Heuss D, Soyka D. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994; 59: 241-249
31. Pfaffenrath V, Diener HC, Isler H, Meyer C, Scholz E, Taneri Z, Wessely P, Zaiser-Kaschel H, Haase W, Fischer W. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-center controlled study. Cephalalgia 1994; 14: 149-155
32. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (Botox) for the treatment of migraine headaches: An open label study. Otolaryngol Head Neck Surg 2000; 123: 669-676
33. Carruthers A, Langtry JA, Carruthers J, Robinson G. Improvement of tension-type headache when treating wrinkles with botulinum toxin A injections. Headache 1999; 39: 662-665
34. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin type A: a pilot study. Headache 2000; 40: 231-236
35. Freund BJ, Schwartz M. A focal dystonia model for subsets of chronic tension headache. Cephalalgia 2000; 20: 433
36. Göbel H, Lindner V, Krack P, Heinze A, Gaartz N, Deuschl G. Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 1999; 19: 455
37. Klapper JA, Mathew NT, Klapper A, Kailasam J. Botulinum toxin type a (BTX-A) for the prophylaxis of chronic daily headache. Cephalalgia 2000; 20: 292-293
38. Krack P, Hornig C, Dorndorf W. Resolution of chronic tension headache after botulinum toxin treatment of idiopathic blepharospasm. Mov Disord 1995; 10: 388
39. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 2000; 4: 31-35
40. Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurology 1997; 4 Suppl 2: S71-73
41. Relja M, Korsic M. Treatment of tension type headache by injections of botulinum toxin type A: double-blind placebo-controlled study. Neurology 1999; 52: A203
42. Relja MA. Treatment of tension-type headache with botulinum toxin: 1-year follow-up. Cephalalgia 2000; 20: 336
43. Relja MA, Klepac N. Botulinum toxin type A as a prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology. 2001; 56 (suppl 3): A349-A350
44. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000; 40: 300-305
45. Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001; 41: 658-664
46. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res 1999; 4: 183-186
47. Smuts JA, Baker MK, Smuts HM, Rheta Stassen JM, Rossouw E, Barnard PWA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol. 1999; 6 (suppl 4): S99-S102
48. Smuts JA, Baker MK, Smuts HM, Stassen JMM, Rossouw E, Barnard PWA. Botulinum toxin type A as prophylactic treatment in chronic tension-type headache. Cephalalgia 1999; 19: 454
49. Smuts JA, Barnard PWA. Botulinum toxin type A in the treatment of headache syndromes: a clinical report of 79 patients. Cephalalgia 2000; 20: 332
50. Zwart JA, Bovim G, Sand T, Sjaastad O. Tension headache: botulinum toxin paralysis of temporal muscles. Headache 1994; 34: 458-462
51. Blumenefeld A. Botulinum toxin type A (Botox) as an effective prophylactic treatment in headache. Cephalalgia 2002; 22: 20
52. Lin JJ, Chang DC. Efficient treatment of chronic tension-type headache with botulinum toxin-A. Cephalalgia 2002; 22: 15
53. Lopez-Lozano JJ, Mata M, Dorado R, Tuduri L. Clinical study of the value of botulinum toxin-A (Botox) in the treatment of chronic tension-type headache with associated pericranial muscle tenderness. Cephalalgia 2002; 22: 32
54. Padberg M, de Bruijn SFTM, Tavy DLJ. Treatment of chronic tension-type headache with botulinum-toxin: a double blind, placebo controlled trial. Cephalalgia 2002; 22: 10
55. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992; 46: 443-446
56. Blumenfeld A. Decrease in headache medication use and cost after botulinum toxin type A (Botox) treatment in a high triptan use population. Presented at the AHS, Istanbul, June 21-23, 2002